HopeStage
Back to all studies
CompletedNCT05204940

Brain and memory markers in depression and dementia research

About this titleRead the official source — NCT05204940
Observational studyAges 60+United States + Canada
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: from 60 years. Other eligibility criteria applied.

Listed locations
Los Angeles and 4 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 27, 2017
Recruitment status
Completed
Enrollment listed in the registry
506
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Behavioural
Locations
United States, Canada
Age range
Over 60 Years
Official registry ID
NCT05204940
Official title
Show the full official title

Neurocognitive and Neuroimaging Biomarkers: Predicting Progression Towards Dementia in Patients With Treatment-resistant Late-life Depression (OPTIMUM-Neuro Study)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Los Angeles, United States · St Louis, United States · New York, United States

2 more locations
  • Pittsburgh, United States
  • Toronto, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Who was this study for?

This study was for people with depression. Listed age limits: from 60 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies